Brain Natriuretic Peptide for Predicting Contrast-Induced Acute Kidney Injury in Patients with Acute Coronary Syndrome Undergoing Coronary Angiography: A Systematic Review and Meta-Analysis

Figure 5

Fagan nomogram of brain natriuretic peptide for the diagnosis of contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing coronary angiography. The pretest probability was set to 50%. The use of brain natriuretic peptide for the detection of contrast-induced acute kidney injury increased the posttest probability to 78% when the brain natriuretic peptide results were positive; the posttest probability decreased to 26% when the brain natriuretic peptide results were negative.